SCHEMBL7401889

SCHEMBL7401889

CCC(C(=O)OCC(C)C)N(C(C)=O)c1ccccc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.40
TSHR P16473 1/20 0.40
CYP3A4 P08684 4/20 0.36
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.34
P2RX4 Q99571 1/20 0.34
ESR1 P03372 1/20 0.34
ADRB2 P07550 1/20 0.33
ADRB1 P08588 1/20 0.33
ADRB3 P13945 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
RAB9A P51151 1/20 0.33
CYP2C9 P11712 3/20 0.32
CYP2C19 P33261 3/20 0.32
CYP1A2 P05177 2/20 0.32
CYP2D6 P10635 2/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
KAT6A Q92794 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7404818 0.86 ALDH1A1 (0.41) ALDH1A1TSHRCYP3A4LMNAP2RX4
SCHEMBL7484093 0.86 ALDH1A1 (0.41) ALDH1A1TSHRLMNAP2RX4RAB9A
SCHEMBL7576541 0.84 TSHR (0.41) ALDH1A1TSHRCYP3A4LMNAPOLB
SCHEMBL6136648 0.81 MEN1 (0.38) ALDH1A1CYP3A4LMNAPOLBESR1
SCHEMBL7237747 0.79 GAA (0.37) ALDH1A1TSHRADRB2ADRB1ADRB3
SCHEMBL7879014 0.78 ALDH1A1 (0.38) ALDH1A1TSHRLMNAADRB2ADRB1
SCHEMBL7227154 0.75 FSCN1 (0.46) ALDH1A1TSHRCYP3A4LMNAL3MBTL1
SCHEMBL8001991 0.74 ALDH1A1 (0.37) ALDH1A1TSHRLMNARAB9ACYP2C9
SCHEMBL5897694 0.74 MTNR1A (0.44) ALDH1A1ESR1
SCHEMBL7237657 0.74 MEN1 (0.37) ALDH1A1TSHRLMNAPOLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0942924-A2 METHODS AND COMPOUNDS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS Elan Pharmaceuticals, Inc. (US) 1999-09-22 EP disclosed
WO-1998022494-A2 METHODS AND COMPOUNDS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR SYNTHESIS ELAN PHARMACEUTICALS, INC. (US) 1998-05-28 WO disclosed